Novartis ADR representing 1 logo

Novartis ADR representing 1

Stock
Stock
Ticker: NVS
NVS

Price

Price

CHART BY

Historical dividends and forecast

Novartis ADR representing 1 has so far distributed $4.74 in 2026. 


$2.077

CHART BY

Frequently asked questions

The market capitalization of Novartis ADR representing 1 is $284.94B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Novartis ADR representing 1 is 29.57. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Novartis ADR representing 1's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.264. EPS indicates the company's profitability on a per-share basis.
Currently, 8 analysts cover Novartis ADR representing 1's stock, with a consensus target price of $158.20. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Novartis ADR representing 1 reported a revenue of $55.35B.
Novartis ADR representing 1's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $22.11B. EBITDA measures the company's overall financial performance.
Novartis ADR representing 1 has a free cash flow of $15.65B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Novartis ADR representing 1 employs approximately 75,267 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Novartis ADR representing 1 is 1.83B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$284.94B
EPS (TTM) 
$5.264
Free Float 
1.83B
P/E ratio (TTM) 
29.57
Revenue (TTM) 
$55.35B
EBITDA (TTM) 
$22.11B
Free Cashflow (TTM) 
$15.65B

Pricing

1D span
$159.88$164.46
52W span
$122.57$170.34

Analyst Ratings

The price target is $158.20 and the stock is covered by 8 analysts.

Buy

4

Hold

4

Sell

0

Information

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Employees
75,267
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
NVS

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation